Medtronic announces cash dividend for third quarter of fiscal year 2026

Core Insights - Medtronic plc's board of directors approved a cash dividend of $0.71 per ordinary share for the third quarter of fiscal year 2026, consistent with a previous increase announced in May 2025 [1] - The company has a strong history of dividend payments, having increased its annual dividend for 48 consecutive years, and is part of the S&P 500 Dividend Aristocrats index [1] - The dividend will be payable on January 16, 2026, to shareholders of record as of December 26, 2025 [1] Company Overview - Medtronic, headquartered in Galway, Ireland, is a leading global healthcare technology company focused on addressing significant health challenges through innovative solutions [2] - The company's mission is to alleviate pain, restore health, and extend life, supported by a workforce of over 95,000 employees across more than 150 countries [2] - Medtronic's technologies and therapies address 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [2]